Helpline 07939 046 030
Freephone 0300 102 17 22*

Glasgow 2026 Everybody is born a Champion

24 July 2026

Thomas Young (Photo credit: George Tewkesbury)

Everybody is Born a Champion

Thomas Young, 2026 Commonwealth Games

The perfect birthday present 

After a crushing injury before the 2022 Commonwealth Games in Birmingham, Thomas Young came roaring back at Glasgow 2026, winning the T38 100m Gold on 27 July, his 26th birthday!

Nerve Tumours UK have again joined forces with RBH Creative Communications, for a fifth successive year and the second part of our 2026 digital media campaign to raise awareness of Neurofibromatosis. 

The campaign features British Para-Sprinter Thomas Young MBE, who has NF1 and has been a patron of the charity since 2024. It will run across 30 rail hubs from 24-30 July 2026, coinciding with the 2026 Commonwealth Games.

Thomas Young is a British Para-Sprinter

He was crowned Paralympic T38 100m Champion at the Tokyo Paralympics in 2021, breaking the European Record in the process. He has won Paralympic Gold, World Silver in 2019 and 2024, World Bronze in 2025 and three times has been crowned European T38 100M Champion. In 2022 he was awarded an MBE for his services to Athletics. We are delighted that Thomas, who is diagnosed with NF1, continues to support the NF community as a Patron of Nerve Tumours UK.

On his way to Gold in Glasgow Photo Credit James Rhodes

What Is Neurofibromatosis?

Neurofibromatosis is an incurable, neuro-genetic condition that causes tumours to grow on nerve endings, affecting over 26,500 children and adults living in the UK.

Neurofibromatosis, collectively known as NF, is the medical group name for Neurofibromatosis Type 1 (NF1), NF2-related-Schwannomatosis (NF2) and Schwannomatosis (SWN).

Combined, NF is one of the most common neuro-genetic conditions, although it can still be classified as a rare condition. NF manifests itself differently from person to person and so it is important that everyone is helped on an individual basis. Parents have a 50% chance of passing this genetic condition onto their child, but 50% of all diagnoses are a first one within the family.

Working For The NF Community

For over 45 yearsNerve Tumours UK has provided support and advice to help the 26,500+ children and adults in the UK diagnosed with NF, along with their carers, family members and wider support network, which can include teachers, employers and all types of healthcare professionals.

We do this through funding a unique specialist support network, comprising regional nursesnational helpline, clinical guidelines, information days, an interactive website, online communities plus medical guidelines/literature.

Support Our Work

Our aim is to meet the needs of the 26,500+ in the NF Community, to ensure that each and every patient has direct access to the correct care path and subsequent services, as well as helping more people to know about and better understand Neurofibromatosis. We are 100% funded by voluntary donations, so are entirely reliant on your fundraising support.

"In May we launched the first part of our 2026 campaign, which posed the question "What Is Neurofibromatosis?", to spark interest amongst those who have not heard of the condition, and to further engage with those who do.

"The second part of the campaign, spanning the 2026 Glasgow Commonwealth Games, feautures one of the charity's patrons, Thomas Young, as we feel it is extremely important to celebrate those living with NF and their achievements. We want the NF Community to know that, with the correct support, such as from our team of Specialist NF Nurses/Advisors, they can achieve their potential.

"We are extremely grateful for Thomas agreeing to lead the campaign once again and send our best wishes for a successful Games!"

– Karen Cockburn, Charity Director
 

"At RBH, we are so proud to be supporting Nerve Tumours UK for the 5th consecutive year. The work they do for people with NF is vitally important and we are committed to helping raise awareness of this little-known condition.

"With this campaign we re-focused on building the profile of the remarkable Thomas Young, a British Para-Sprinter with NF1 who is Patron of Nerve Tumours UK. Our hope is that this campaign goes a long way in bringing both Nerve Tumours UK and Thomas Young front of mind among the general public, especially with Thomas recently running his personal best in preparation for Glasgow!"

- RBH Creative Communication https://rbh.co.uk/
 

A special thank you to Alexion AstraZeneca Rare Disease for their support sponsoring this campaign. They had no input into the content of the campaign. Thanks also to JCDecaux for their continued support with booking and facilitating the advertising locations.

Billboard location map

Click this link for the exact locations (some require zooming in) of our digital poster campaign.

NTUK Rail Hub Locations

The campaign features on billboards at these railway stations/shopping centres: Birmingham New Street Station, Blackfriars Station, Brighton Station, Bristol Temple Meads Station, Cambridge Station, Edinburgh Waverley Station, Glasgow Railway Station, Glasgow St Enoch Mall, Leeds Station, Liverpool Lime Street Station, London Bridge Station, London City Thameslink Station, London Elephant and Castle Station, London Euston Station, London Kings Cross Station, London St Pancras Station, London Waterloo Station, Manchester Piccadilly Station, Nottingham Station, Oxford Parkway Station, Reading Station, Sheffield Station

Share our awareness campaign on your social media or take a photo on location.
Tag @nervetumoursuk with #MakeNFVisible in your posts

 

Congratulations to Thomas Young T38, 100 Metre Champion Glasgow 2026!

"After the heartbreak of missing 2022, I’m so happy to finally line up and be on the top step of the podium at the Commonwealth Games Glasgow 2026. It’s been a massive journey of ups and downs but race on the 27th July 2026 made it all worth it!" Thomas Young on his championship record  

Glasgow Central Station, Thomas Young arrives!

Let the games begin! Tom will be raising the flag for Team England and the NF Community on Monday 27 July.

London Euston Station

London City Thameslink

London St Pancras Station

London Waterloo Station

London Blackfriars Station

London Bridge Station

London Elephant & Castle Station

Masterclasses in NF: Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Prof. Dr. Berthold Pemp

OT Sabine Koinig

Masterclasses in NF: Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Assoc. Prof. Dr. Gregor Kasprian

Dr. Hector Salvador, MD

Masterclasses in NF: The Patients’ Perspective: A Masterclass on NF Care Held by NF Patients

Masterclasses in NF: Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

 

Michel Kalamarides MD

Masterclasses in NF: Management Of Plexiform Neurofibromatosis in NF1- Rianne Oosterbrink, Justus L Groen, Karine Lascelles

Masterclasses in NF1: 1.Management Of Plexiform Neurofibromatosis in NF1

Rianne Oosterbrink MD

Justus L Groen MD

Karine Lascelles MD

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK